Neurogen Corporation Announces Webcast of Third Quarter 2009 Financial Results on November 6

BRANFORD, Conn.--(BUSINESS WIRE)--Neurogen Corporation (NASDAQ:NRGN), a drug development company, announced today that it will release its third quarter 2009 financial results on Friday, November 6, 2009 before the opening of the U.S. financial markets. The Company will host a conference call and live audio webcast that same day at 8:30 am EST to review the results.

The news release and live webcast may be accessed through the investor relations section of the Company's web site: www.neurogen.com. The webcast will also be archived in this section, under "Events Calendar and Replays."

About Neurogen

Neurogen Corporation is a drug development company historically focused on small-molecule drugs to improve the lives of patients suffering from psychiatric and neurological disorders with significant unmet medical need. Neurogen has entered into a previously announced agreement to merge into Ligand Pharmaceuticals, Inc. The merger is expected to closed by the end of 2009.